Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.
第一作者:
Jessica R,Allegretti
第一单位:
*Department of Medicine, Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts; and †Department of Gynecologic Oncology, University of Calgary, Tom Baker Cancer Care, Foothills Medical Center, Alberta, Canada.
作者:
主题词
病例对照研究(Case-Control Studies);女(雌)性(Female);人类(Humans);免疫减弱宿主(Immunocompromised Host);免疫抑制剂(Immunosuppressive Agents);炎性肠疾病(Inflammatory Bowel Diseases);预后(Prognosis);危险因素(Risk Factors);宫颈非典型增生(Uterine Cervical Dysplasia)
DOI
10.1097/MIB.0000000000000338
PMID
25895005
发布时间
2022-12-07
- 浏览8

Inflammatory bowel diseases
1089-97页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文